An alternative approach to circumvent low aqueous solubility for a BCS class ii compound using lipid-based suspensions
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: NMS-009
- By: CORREIA, Gabriel (Thermo Fisher Scientific, Netherlands)
- Co-author(s): Mr Gabriel Correia, Senior Scientist Formulation
PhD Dipanwita De, Formulation
Most of new chemical entities require nontraditional formulation approaches to circumvent low solubility in the GI fluids and insufficient intestinal permeation leading to low drug exposure.
One of the strategies used to improve the bioavailability for BSC class II and IV make use of lipid-based drug delivery systems, where the drug can be either.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019